Advances in Anticancer Drug Research
A special issue of Applied Sciences (ISSN 2076-3417). This special issue belongs to the section "Biomedical Engineering".
Deadline for manuscript submissions: closed (20 February 2024) | Viewed by 314
Special Issue Editors
Interests: medicinal chemistry; organic synthesis; drug discovery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Recent breakthroughs in the understanding of the mechanisms that regulate the development and spread of tumors and the immune response to them have led to new approaches in the treatment of cancer. The options available to patients now include immunotherapy and targeted therapy, alongside classical endocrine, radiation, and chemotherapies. A better understanding of the mechanism of action of these pharmaceuticals and their structure–activity relationships is essential in order to improve treatments and their applicability to a large variety of tumors. This Special Issue of Applied Sciences, entitled “Advances in Anticancer Drug Research”, aims to gather new insights on the topic of oncology drug discovery. We encourage the submission of contributions covering the design and synthesis of anti-cancer pharmaceuticals, as well as in vivo/in vitro/in silico studies for the evaluation of delivery and activity. Original research papers and review articles are welcomed.
Dr. Alfonso Zambon
Dr. Paolo Zardi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Applied Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- anticancer drugs
- chemotherapy
- drug discovery
- immunotherapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
